New pill for rare gene-driven cancers shows early promise but trial halted
NCT ID NCT06005974
First seen Feb 06, 2026 · Last updated May 15, 2026 · Updated 10 times
Summary
This study tested an experimental drug called REC-4881 in 18 adults aged 55+ with advanced solid tumors that have AXIN1 or APC gene mutations. The goal was to see if the drug is safe and shrinks tumors. The trial was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
American Oncology Partners of Maryland, PA
Bethesda, Maryland, 20817, United States
-
Avera Cancer Institute
Sioux Falls, South Dakota, 57105, United States
-
Cancer Specialists of North Florida
Fleming Island, Florida, 32003, United States
-
Eastern Connecticut Hematology & Oncology Associates
Norwich, Connecticut, 06360, United States
-
Hunterdon Hematology Oncology
Hillsborough, New Jersey, 08844, United States
-
Mary Crowley Cancer Research Centers
Dallas, Texas, 75231, United States
-
Medical Oncology Hematology Consultants
Newark, Delaware, 19713, United States
-
Mission Cancer And Blood
Des Moines, Iowa, 50314, United States
-
Rocky Mountain Cancer Centers
Denver, Colorado, 80218, United States
-
Saint Luke's Hospital
Kansas City, Missouri, 64111, United States
-
Sansum Clinic
Santa Barbara, California, 93105, United States
-
Sharp Memorial Hospital
San Diego, California, 92123, United States
-
Virginia Cancer Specialists
Fairfax, Virginia, 22031, United States
Conditions
Explore the condition pages connected to this study.